Skip to main content

Provention Bio, Inc.

PRVBDelisted Apr 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001695357

Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.

13F holders, Q1 2021

Institutional positions in Provention Bio, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
120
No complete 13F data for Q4 2020
Shares held
23.8M
No complete 13F data for Q4 2020
Total value
$249.3M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting PRVB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 120 institutions
Q1 2021: 120 institutionsQ2 2021: 125 institutionsQ3 2021: 115 institutionsQ4 2021: 112 institutionsQ1 2022: 113 institutionsQ2 2022: 115 institutionsQ3 2022: 112 institutionsQ4 2022: 133 institutionsQ1 2023: 183 institutionsQ2 2023: 1 institutionQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2021: $249.3M
Q1 2021: $249.3MQ2 2021: $196.9MQ3 2021: $142.9MQ4 2021: $133.0MQ1 2022: $177.0MQ2 2022: $99.9MQ3 2022: $187.1MQ4 2022: $477.4MQ1 2023: $1.47BQ2 2023: $2.80MQ3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PRVB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20231$2.80M
Q1 2023183$1.47B
Q4 2022133$477.4M
Q3 2022112$187.1M
Q2 2022115$99.9M
Q1 2022113$177.0M
Q4 2021112$133.0M
Q3 2021115$142.9M
Q2 2021125$196.9M
Q1 2021120$249.3M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Provention Bio, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding PRVB in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Parallax Volatility Advisers, L.P.2,615$27.0K0.00%––
The PNC Financial Services Group, Inc.2,225$23.0K0.00%––
Bank of Montreal2,311$22.0K0.00%––
Penserra Capital Management LLC1,435$15.0K0.00%––
Bank Julius Baer & Co. Ltd, Zurich1,250$13.0K0.00%––
TCI Wealth Advisors, Inc.1,100$12.0K0.01%––
WealthShield Partners, LLC1,000$10.0K0.00%––
TSFG, LLC1,000$10.0K0.01%––
International Assets Investment Management, LLC546$7.00K0.00%––
Massmutual Trust Co FSB445$5.00K0.00%––
Plante Moran Financial Advisors, LLC500$5.00K0.00%––
Barclays PLC318$3.00K0.00%––
Harbour Investments, Inc.260$3.00K0.00%––
Bedel Financial Consulting, Inc.251$3.00K0.00%––
Providence Capital Advisors, LLC275$3.00K0.00%––
Whittier Trust Co190$2.00K0.00%––
Reilly Financial Advisors, LLC200$2.00K0.00%––
Daiwa Securities Group Inc.106$1.00K0.00%––
Captrust Financial Advisors52$1.00K0.00%––
Coastal Capital Group, Inc.100$1.00K0.00%––